Drug Database
Back to search

Poland· PL-100350493

Fostex

A formoterol und beclometason product containing beclometasoni dipropionas anhydricus + formoteroli fumaras dihydricus, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 11 of our 19 countries.

ATC R03AK08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFostexATCR03AK08REGISTER NO.PL-100350493PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about beclometasoni dipropionas anhydricus + formoteroli fumaras dihydricusAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Formoterol und beclometason is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AK08 (formoterol und beclometason), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search formoterol und beclometason products by name

Formoterol und beclometason · ATC R03AK08

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Beclometasoni dipropionas anhydricus + Formoteroli fumaras dihydricus
Manufacturer
Chiesi Farmaceutici S.p.A.
Country
Poland (PL)
ATC code
R03AK08
ATC class
Formoterol und Beclometason
Defined daily dose
24 mcg, Inhal
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909991245696
    1 poj.po 180 daw.
    PLN 155.83

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Formoterol und beclometason in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All formoterol und beclometason products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aironis, Beclometason/Formoterol Cipla
  • Belgium · Beclometasone/Formoterol Eg, Béclométasone/Formotérol Genetic
  • Bulgaria · Beclometasone/Formoterol Pharmascience, Бефоза
  • Cyprus · Beclometasone Formoterol Genetic, Brelung
  • Czechia · Beclometason/Formoterol Cipla, Beklometason/Formoterol Cipla
  • Germany · Aforbe, Beclometason/ Formoterol Cipla
  • Denmark · Aforbe, Ambofoz
  • Estonia · Aforbe, Bedufora
  • Spain · Bibecfo, Blocetta
  • Finland · Aforbe, Befoair
  • France · Béclométasone/Formotérol Biogaran, Béclométasone/Formotérol Cipla
  • United Kingdom (Northern Ireland) · Aeriluma, Formexa
  • Greece · Beclometasone+formoterol Stada, Breair
  • Croatia · Aforbe, Befodair
  • Hungary · Forobex, Foster
  • Ireland · Beclometasone/Formoterol, Fostair
  • Iceland · Innovair, Laberon
  • Italy · Alabaster, Beclometasone E Formoterolo Cipla
  • Lithuania · Aforbe, Bedufora
  • Luxembourg · Inuvair, Inuvair Nexthaler
  • Latvia · Aforbe, Beclometasone/Formoterol Genetic
  • Malta · Beclometasone Formoterol Genetic, Foster
  • Netherlands · Ambofoz, Beclometason/Formoterol Allgen
  • Norway · Aforbe, Ambofoz
  • Portugal · Beclofor, Beclometasona Formoterol Genetic
  • Romania · Beclometazonă /Formoterol Stada, Beclometazona/Formoterol Cipla
  • Sweden · Aforbe, Ambofoz
  • Slovenia · Formodual, Foster
  • Slovakia · Beklometazón/Formoterol Stada, Bibecfo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ddca59b5-c4b4-4e01-925c-7b9694429a07
GET /v1/drugs/ddca59b5-c4b4-4e01-925c-7b9694429a07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol inhalacyjny, roztwór",
  "source": "urpl",
  "strength": "(200 mcg + 6 mcg)/dawkę inh.",
  "packaging": "05909991245696 ¦ Rp ¦ 111915\n1 poj. 180 dawek",
  "substance": "Beclometasoni dipropionas anhydricus 200 mcg/dawkę + Formoteroli fumaras dihydricus 6 mcg/dawkę",
  "common_name": "Beclometasoni dipropionas anhydricus + Formoteroli fumaras dihydricus",
  "pl_product_id": "100350493",
  "pozwolenie_nr": "22764",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about formoterol und beclometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console